CSL Limited (ASX: CSL) Share Price and News
Chart and Price Data
|Avg Daily Volume|
|52 Week Range||-|
|Year Return (Capital)|
CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative biotherapies and influenza vaccines to protect public health and help people with life-threatening medical conditions live full lives.
While the company has been in operation for more than a century, CSL shares were first listed on the ASX in 1994 within the healthcare sector – today, CSL sits as one of the largest companies on the ASX. The CSL share price has risen exponentially since first listing on the ASX and is now considered a traditional growth stock – CSL is known to lift profit, year-on-year, and invest much of it back into research and development and capital expenditure.
CSL’s operational businesses include CSL Behring and Seqirus, and the company operates predominantly in Australia, the USA, Germany, the United Kingdom and Switzerland.
CSL Limited (ASX: CSL) Latest News
Tristan Harrison | February 20, 2020 2:11pm
The exit of Holden teaches us several different things about investing, about finance and about business operations. More »
Brendon Lau | February 19, 2020 2:52pm
The Ansell Limited (ASX: ANN) marches towards its record high but Citigroup thinks this is as good as it gets and downgrades the stock.... More »
Rhys Brock | February 18, 2020 12:37pm
Here are 3 companies that, while still speculative and risky in nature, have the potential to grow into tomorrow’s ASX healthcare blue chips. More »
Tristan Harrison | February 15, 2020 11:15am
These were 4 of the biggest news items from the ASX 200 (ASX:XJO) this week. Read how this affected these individual companies. More »
Regan Pearson | February 15, 2020 10:00am
Here’s how to find the next Xero Limited (ASX: XRO) or Afterpay Ltd (ASX: APT). More »